科前生物(688526.SH)：第三季度净利润同比上升9.17%

Core Viewpoint - 科前生物 reported a decline in operating revenue for Q3 2025, while net profit showed an increase, indicating mixed financial performance [1] Financial Performance - Operating revenue for Q3 2025 was 251 million yuan, a year-on-year decrease of 5.44% [1] - Net profit attributable to shareholders was 118 million yuan, reflecting a year-on-year increase of 9.17% [1] - Net profit attributable to shareholders after deducting non-recurring gains and losses was 84.62 million yuan, a year-on-year decrease of 7.06% [1]